Kedrion Biopharma
Cory Molzahn currently serves as Corporate Account Director at Kedrion Biopharma, specializing in BioPharma Acute Care Sales for Plasma and Rare Diseases products since April 2023. Prior to this role, Cory held the position of Regional District Manager at PharmScript LLC from December 2018 to April 2023, and earlier gained experience as a Sales Consultant at Medline Industries, Inc. from February 2001 to December 2018. Cory holds a Bachelor of Arts degree in Accounting from Saint Mary's University of Minnesota.
This person is not in any teams
This person is not in any offices
Kedrion Biopharma
19 followers
Kedrion Biopharma is a biopharmaceutical company that collects and fractionates blood plasma to produce and distribute worldwide plasma-derived therapies for use in treating and preventing rare and serious diseases and conditions. In 2022, Kedrion joined forces with BPL (Bio Products Laboratory). Based in the United Kingdom, BPL has over 60 years of experience in the supply of high-quality plasma-derived medicines to treat rare diseases. Kedrion distributes its products in over 100 countries around the world. We have plants in Italy, Hungary, UK and North America, and plasma collection centers in the US and in the Czech Republic. With these figures we are the world’s 5th top player in the field of plasma-derived products. Our goal is to build a diverse and professional workforce, providing job opportunities for talented external candidates as well as internal employees who aim to grow with us. Because our work includes so many interests and skills – from Research to Sales; Plasma Collection to Production – there are abundant possibilities for learning and growth. Kedrion builds bridges: from donors to patients, from plasma to therapies, from challenge to hope.